Furthermore, growth kinetics (Fig. 2C and supplementary video), clonogenic capacity (Fig. 2D) and tumorsphere formation (Fig. 2E, Fig. S2C) were strongly impaired upon RNF40 loss in HER2+-BC cell lines. Here, ERBB2 is linked to breast cancer.